Serveur d'exploration sur la rapamycine et les champignons - Exploration (Accueil)

Index « Mesh.i » - entrée « Molecular Targeted Therapy »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Molecular Structure < Molecular Targeted Therapy < Molecular Weight  Facettes :

List of bibliographic references indexed by Molecular Targeted Therapy

Number of relevant bibliographic references: 23.
[0-20] [0 - 20][0 - 23][20-22][20-40]
Ident.Authors (with country if any)Title
000032 (2020) Loukman Omarjee [France] ; Anne Janin [France] ; Frédérique Perrot [France] ; Bruno Laviolle [France] ; Olivier Meilhac [France] ; Guillaume Mahe [France]Targeting T-cell senescence and cytokine storm with rapamycin to prevent severe progression in COVID-19.
000440 (2018) Arash Soltani [Iran] ; Amirhossein Bahreyni [Iran] ; Nadia Boroumand [Iran] ; Mostafa Karimi Roshan [Iran] ; Majid Khazaei [Iran] ; Mikhail Ryzhikov [États-Unis] ; Saman Soleimanpour [Iran] ; Amir Avan [Iran] ; Seyed Mahdi Hassanian [Iran]Therapeutic potency of mTOR signaling pharmacological inhibitors in the treatment of proinflammatory diseases, current status, and perspectives.
000442 (2018) Camilla Evangelisti [Italie] ; Francesca Chiarini [Italie] ; James A. Mccubrey [États-Unis] ; Alberto M. Martelli [Italie]Therapeutic Targeting of mTOR in T-Cell Acute Lymphoblastic Leukemia: An Update.
000467 (2018) Carolina Simioni [Italie] ; Alberto M. Martelli [Italie] ; Giorgio Zauli [Italie] ; Marco Vitale [Italie] ; James A. Mccubrey [États-Unis] ; Silvano Capitani [Italie] ; Luca M. Neri [Italie]Targeting the phosphatidylinositol 3-kinase/Akt/mechanistic target of rapamycin signaling pathway in B-lineage acute lymphoblastic leukemia: An update.
000613 (2018) Kara M. Ruicci [Canada] ; Nicole Pinto [Canada] ; Mohammed I. Khan [Canada] ; John Yoo [Canada] ; Kevin Fung [Canada] ; Danielle Macneil [Canada] ; Joe S. Mymryk [Canada] ; John W. Barrett [Canada] ; Anthony C. Nichols [Canada]ERK-TSC2 signalling in constitutively-active HRAS mutant HNSCC cells promotes resistance to PI3K inhibition.
000617 (2018) Alberto M. Martelli [Italie] ; Francesca Buontempo [Italie] ; James A. Mccubrey [États-Unis]Drug discovery targeting the mTOR pathway.
000673 (2018) Wakana Saso [Japon] ; Senko Tsukuda [Japon] ; Hirofumi Ohashi [Japon] ; Kento Fukano [Japon] ; Ryo Morishita [Japon] ; Satoko Matsunaga [Japon] ; Mio Ohki [Japon] ; Akihide Ryo [Japon] ; Sam-Yong Park [Japon] ; Ryosuke Suzuki [Japon] ; Hideki Aizaki [Japon] ; Masamichi Muramatsu [Japon] ; Camille Sureau [France] ; Takaji Wakita [Japon] ; Tetsuro Matano [Japon] ; Koichi Watashi [Japon]A new strategy to identify hepatitis B virus entry inhibitors by AlphaScreen technology targeting the envelope-receptor interaction.
000686 (2017) Darcy A. Kerr [États-Unis] ; Satya Vara Prasad Busarla [Oman] ; Devon C. Gimbel [États-Unis] ; Aliyah R. Sohani [États-Unis] ; Rosalynn M. Nazarian [États-Unis]mTOR, VEGF, PDGFR, and c-kit signaling pathway activation in Kaposi sarcoma.
000999 (2016) Lijun Xie [République populaire de Chine] ; Jie Huang [République populaire de Chine] ; Xiaoming Chen [République populaire de Chine] ; Hui Yu [République populaire de Chine] ; Kualiang Li [République populaire de Chine] ; Dan Yang [République populaire de Chine] ; Xiaqin Chen [République populaire de Chine] ; Jiayin Ying [République populaire de Chine] ; Fusheng Pan [République populaire de Chine] ; Youbing Lv [République populaire de Chine] ; Yuanrong Cheng [République populaire de Chine]Synthesis of Rapamycin Derivatives Containing the Triazole Moiety Used as Potential mTOR-Targeted Anticancer Agents.
000A97 (2016) Ayman A M. Alameen [Italie, Soudan] ; Carolina Simioni [Italie] ; Alberto M. Martelli [Italie] ; Giorgio Zauli [Italie] ; Simona Ultimo [Italie] ; James A. Mccubrey [États-Unis] ; Arianna Gonelli [Italie] ; Giorgia Marisi [Italie] ; Paola Ulivi [Italie] ; Silvano Capitani [Italie] ; Luca M. Neri [Italie]Healthy CD4+ T lymphocytes are not affected by targeted therapies against the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia.
000C02 (2015) Christoph Aderhold [Allemagne] ; Anne Faber [Allemagne] ; Claudia Umbreit [Allemagne] ; Richard Birk [Allemagne] ; Christel Weiss [Allemagne] ; Jörg Ulrich Sommer [Allemagne] ; Karl Hörmann [Allemagne] ; Johannes David Schultz [Allemagne]Targeting mTOR and AREG with everolimus, sunitinib and sorafenib in HPV-positive and -negative SCC.
000C17 (2015) Christoph Aderhold [Allemagne] ; Anne Faber [Allemagne] ; Claudia Umbreit [Allemagne] ; Anja Chakraborty [Allemagne] ; Andre Bockmayer [Allemagne] ; Richard Birk [Allemagne] ; Jörg Ulrich Sommer [Allemagne] ; Karl Hörmann [Allemagne] ; Johannes David Schultz [Allemagne]Small molecules alter VEGFR and PTEN expression in HPV-positive and -negative SCC: new hope for targeted-therapy.
000D34 (2015) Kelan A. Hlavaty [États-Unis] ; Xunrong Luo [États-Unis] ; Lonnie D. Shea [États-Unis] ; Stephen D. Miller [États-Unis]Cellular and molecular targeting for nanotherapeutics in transplantation tolerance.
000D82 (2014) Simon C. Johnson [États-Unis]Translational Medicine. A target for pharmacological intervention in an untreatable human disease.
000D87 (2014) Camilla Evangelisti [Italie] ; Cecilia Evangelisti [Italie] ; Francesca Chiarini [Italie] ; Annalisa Lonetti [Italie] ; Francesca Buontempo [Italie] ; Daniela Bressanin [Italie] ; Alessandra Cappellini [Italie] ; Ester Orsini [Italie] ; James A. Mccubrey [États-Unis] ; Alberto M. Martelli [Italie]Therapeutic potential of targeting mTOR in T-cell acute lymphoblastic leukemia (review).
000E34 (2014) Ronald C. Bruntz [États-Unis] ; Craig W. Lindsley [États-Unis] ; H Alex Brown [États-Unis]Phospholipase D signaling pathways and phosphatidic acid as therapeutic targets in cancer.
000E42 (2014) Stephen I. Deutsch [États-Unis] ; Amy H. Tang [États-Unis] ; Jessica A. Burket [États-Unis] ; Andrew D. Benson [États-Unis]NMDA receptors on the surface of cancer cells: target for chemotherapy?
000E61 (2014) Melissa Sokolosky [États-Unis] ; William H. Chappell [États-Unis] ; Kristin Stadelman [États-Unis] ; Stephen L. Abrams [États-Unis] ; Nicole M. Davis [États-Unis] ; Linda S. Steelman [États-Unis] ; James A. Mccubrey [États-Unis]Inhibition of GSK-3β activity can result in drug and hormonal resistance and alter sensitivity to targeted therapy in MCF-7 breast cancer cells.
000E72 (2014) Ozan Yazici [Turquie] ; Mehmet Ali Nahit Sendur [Turquie] ; Sercan Aksoy [Turquie]Hepatitis C virus reactivation in cancer patients in the era of targeted therapies.
000E77 (2014) Tiffany N. Caza [États-Unis] ; David R. Fernandez [États-Unis] ; Gergely Talaber [États-Unis] ; Zachary Oaks [États-Unis] ; Mark Haas [États-Unis] ; Michael P. Madaio [États-Unis] ; Zhi-Wei Lai [États-Unis] ; Gabriella Miklossy [États-Unis] ; Ram R. Singh [États-Unis] ; Dmitriy M. Chudakov [Russie] ; Walter Malorni [Italie] ; Frank Middleton [États-Unis] ; Katalin Banki [États-Unis] ; Andras Perl [États-Unis]HRES-1/Rab4-mediated depletion of Drp1 impairs mitochondrial homeostasis and represents a target for treatment in SLE.
001014 (2013) Keren Yizhak [Israël] ; Orshay Gabay ; Haim Cohen ; Eytan RuppinModel-based identification of drug targets that revert disrupted metabolism and its application to ageing.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/RapamycinFungusV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Molecular Targeted Therapy" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Molecular Targeted Therapy" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    RapamycinFungusV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Molecular Targeted Therapy
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Thu Nov 19 21:55:41 2020. Site generation: Thu Nov 19 22:00:39 2020